Among CTNNB1, CCND1 and NKD1 we chose CTNNB1 as our candidate gene, as CTNNB1 is a key component of Wnt/β-catenin signaling pathway, and almost 50–90% of HB has the CTNNB1 mutation. This evidence concerns the gene CTNNB1 and hemoglobin measurement.